Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emilio Francesco Giunta

Showing results (11-20 of 56) with videos related to

Pageof 6
Sort By:
Cancers|July 13, 2024
A Head-to-Head Comparison of the First-Line Treatments for Locally Advanced or Metastatic Urothelial Cancer: Is There Still a Role for Chemotherapy?Lorenzo Gasperoni, Luna Del Bono, Andrea Ossato, et al.
Critical Reviews in Oncology/Hematology|October 24, 2024
Pharmacological treatment landscape of non-metastatic hormone-sensitive prostate cancer: A narrative review on behalf of the meet-URO GroupEmilio Francesco Giunta, Giandomenico Roviello, Vincenza Conteduca, et al.
Journal of Oncology|January 10, 2023
Hepatocellular Carcinoma: Current Therapeutic Algorithm for Localized and Advanced DiseaseAnju Jose, Maria Grazia Bavetta, Erika Martinelli, et al.
Cancers|September 28, 2021
Tackling Refractory Metastatic Colorectal Cancer: Future PerspectivesNicola Personeni, Valeria Smiroldo, Emilio Francesco Giunta, et al.
Exploration of Targeted Anti-Tumor Therapy|September 1, 2022
Role of liquid biopsy for thoracic cancers immunotherapyRaimondo Di Liello, Flora Cimmino, Soraya Simón, et al.
Frontiers in Oncology|September 6, 2021
Adjuvant Treatment in Pancreatic Cancer: Shaping the Future of the Curative SettingAnnalisa Pappalardo, Emilio Francesco Giunta, Giuseppe Tirino, et al.
Frontiers in Oncology|July 1, 2022
Beyond Crizotinib: A Systematic Review and Meta-Analysis of the Next-Generation ALK Inhibitors as First-Line Treatment for ALK-Translocated Lung CancerEmilio Francesco Giunta, Alessio Signori, Howard Jack West, et al.
Pharmaceuticals (Basel, Switzerland)|April 3, 2021
How to Treat Hepatocellular Carcinoma in Elderly PatientsPiera Federico, Emilio Francesco Giunta, Annalisa Pappalardo, et al.
Therapeutic Advances in Medical Oncology|July 3, 2020
Optimal treatment strategy for metastatic melanoma patients harboring <i>BRAF-V600</i> mutationsEmilio Francesco Giunta, Vincenzo De Falco, Stefania Napolitano, et al.
Cancers|October 13, 2021
Molecular Characterization of Prostate Cancers in the Precision Medicine EraEmilio Francesco Giunta, Laura Annaratone, Enrico Bollito, et al.
Pageof 6

Showing results (11-20 of 56) with videos related to

Sort By:
Pageof 6
Cancers|July 13, 2024
A Head-to-Head Comparison of the First-Line Treatments for Locally Advanced or Metastatic Urothelial Cancer: Is There Still a Role for Chemotherapy?Lorenzo Gasperoni, Luna Del Bono, Andrea Ossato, et al.
Critical Reviews in Oncology/Hematology|October 24, 2024
Pharmacological treatment landscape of non-metastatic hormone-sensitive prostate cancer: A narrative review on behalf of the meet-URO GroupEmilio Francesco Giunta, Giandomenico Roviello, Vincenza Conteduca, et al.
Journal of Oncology|January 10, 2023
Hepatocellular Carcinoma: Current Therapeutic Algorithm for Localized and Advanced DiseaseAnju Jose, Maria Grazia Bavetta, Erika Martinelli, et al.
Cancers|September 28, 2021
Tackling Refractory Metastatic Colorectal Cancer: Future PerspectivesNicola Personeni, Valeria Smiroldo, Emilio Francesco Giunta, et al.
Exploration of Targeted Anti-Tumor Therapy|September 1, 2022
Role of liquid biopsy for thoracic cancers immunotherapyRaimondo Di Liello, Flora Cimmino, Soraya Simón, et al.
Frontiers in Oncology|September 6, 2021
Adjuvant Treatment in Pancreatic Cancer: Shaping the Future of the Curative SettingAnnalisa Pappalardo, Emilio Francesco Giunta, Giuseppe Tirino, et al.
Frontiers in Oncology|July 1, 2022
Beyond Crizotinib: A Systematic Review and Meta-Analysis of the Next-Generation ALK Inhibitors as First-Line Treatment for ALK-Translocated Lung CancerEmilio Francesco Giunta, Alessio Signori, Howard Jack West, et al.
Pharmaceuticals (Basel, Switzerland)|April 3, 2021
How to Treat Hepatocellular Carcinoma in Elderly PatientsPiera Federico, Emilio Francesco Giunta, Annalisa Pappalardo, et al.
Therapeutic Advances in Medical Oncology|July 3, 2020
Optimal treatment strategy for metastatic melanoma patients harboring <i>BRAF-V600</i> mutationsEmilio Francesco Giunta, Vincenzo De Falco, Stefania Napolitano, et al.
Cancers|October 13, 2021
Molecular Characterization of Prostate Cancers in the Precision Medicine EraEmilio Francesco Giunta, Laura Annaratone, Enrico Bollito, et al.
Pageof 6